Affordable genome sequencing is coming soon, but few doctors appear ready to deal with the difficult issues this technology could raise. Suppose a doctor sequences a genome for cardiac data, but finds genes indicating a very high cancer risk in the process. Would the doctor have an obligation to tell the patient? “Doctors aren’t prepared for these big conversations,” said Stanford law professor Hank Greeley.
Is Personalized Medicine Anti-Establishment?